What is Exelderm used for?

Exelderm is indicated for Pityriasis versicolor, Tinea corporis, Tinea cruris, Tinea pedis.

Exelderm is developed by Journey.

What development phase is Exelderm in?

Exelderm is FDA-approved (marketed).

What are the side effects of Exelderm?

Common side effects include itching, burning or stinging.

What is the generic name of Exelderm?

SULCONAZOLE is the generic (nonproprietary) name of Exelderm.

Last reviewed 2026-04-20 · How we verify

Exelderm (SULCONAZOLE)

Journey · FDA-approved approved Small molecule Quality 36/100

Exelderm (Sulconazole) is a small molecule azole antifungal medication originally developed by Ranbaxy and currently owned by Journey. It targets the Cytochrome P450 2C19 enzyme and is FDA-approved for treating various fungal infections such as pityriasis versicolor, tinea corporis, tinea cruris, and tinea pedis. Exelderm is off-patent and has no active Orange Book patents, indicating it is available as a generic medication. As an azole antifungal, it works by inhibiting the growth of fungi. Key safety considerations include potential skin irritation and allergic reactions.

At a glance

Generic name	SULCONAZOLE
Sponsor	Journey
Drug class	Azole Antifungal
Target	Cytochrome P450 2C19
Modality	Small molecule
Therapeutic area	Cardiovascular
Phase	FDA-approved
First approval	1985

Approved indications

Pityriasis versicolor
Tinea corporis
Tinea cruris
Tinea pedis

Common side effects

itching
burning or stinging

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Exelderm CI brief — competitive landscape report
Exelderm updates RSS · CI watch RSS
Journey portfolio CI